Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies

Renal Failure

Volumn 28, Issue 6, 2006, Pages 461-467

  Drakopoulos, Anastasios ^a   Goumenos, Dimitrios S ^a   Vlachojannis, John G ^a   Tsakas, Sotiris ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Endothelin receptors; Proteinuria; Renal disease

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; REMISSION;

ADULT; ENDOTHELIN-1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PROTEINURIA; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

EID: 33747802066     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600778944     Document Type: Article

References (22)

1. Kohan DE. Endothelins in the normal and diseased kidney. Am. J. Kidney Dis. 1997;29(1):2-26.
2. Herizi A, Jover B, Bouriquet N, Mimran A. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade. Hypertension 1998;31(1):10-14.
3. Cybulsky AV, Stewart DJ, Cybulski MI. Glomerular epithelial cells produce endothelin-1. J. Am. Soc. Nephrol. 1993;3(7):1398-1404.
4. Benigni, A. Endothelin antagonists in renal disease. Kidney Int. 2000;57(4):1778-1794.
5. Benigni A, Remuzzi G. Endothelin receptors antagonists: which are the therapeutic perspectives in renal disease? Nephrol. Dial. Transplant. 1998;13(11):5-7.
6. Benigni A, Zoja C, Corna D, Orisio S, Facchinetti D, Benatti L, Remuzzi G. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am. J. Kidney Dis. 1996;27(3):416-423.
7. Sugimoto K, Fujimori A, Yuyama H, Tahara A, Fujimara A. Renal protective effect of YM598, a selective endothelin type A receptor antagonist. J. Cardiovasc. Pharmacol. 2004;44(S):451-454.
8. Jerums G, Panagiotopoulos S, Tsalamandris C, Allen T, Gilbert RE, Comper WD. Why is proteinuria such an important risk factor for progression in clinical trials? Kidney Int. 1997;52(Suppl. 63):S87-S92.
9. 1 in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol. Dial. Transplant. 2002; 17(12):2145-2152.
10. Remuzzi G. Nephropathic nature of proteinuria. Curr. Opin. Nephrol. Hypert. 1999;8(6):655-663.
11. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DCH. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J. Am. Soc. Nephrol. 1997;8(10):1537-1545.
12. Williams MA, Lowrie JI. Fixation of tissue for morphometric study. In: Bach FH, Lock EA, eds., Nephrotoxicity in Experimental and Clinical Situations, Part 1. Dordrecht: Martinus Nijhoff;1987:141-166.
13. Vlachojannis JG, Tsakas S, Petropoulou C, Kurz P. Increased renal excretion of endothelin-1 in nephrotic patients. Nephrol. Dial. Transplant. 1997;12(3):470-473.
14. Healy E, Brady HR. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr. Opin. Nephrol. 1998;7(5):525-530.
15. Chatziantoniou C, Boffa JJ, Tharaux PL, Flamant, M.; Ronco, P.; Dussaule, J.C. Progression and regression in renal vascular and glomerular fibrosis. Int. J. Exp. Pathol. 2004;85(1):1-11.
16. Takahashi K, Totsune K, Mouri T. Endothelin in chronic renal failure. Nephron. 1994;66(4):373-379.
17. Vlachojannis JG, Tsakas S, Petropoulou C, Goumenos DS, Alexandri S. Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria. Clin. Nephrol. 2002;58(5):337-343.
18. Suga SI, Yasui N, Yoshihara F, Horio T, Kawano Y, Kangawa K, Johnson R. Endothelin A receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms. J. Am. Soc. Nephrol. 2003;14:397-406.
19. Girchev R, Backer A, Markova P, Kramer HJ. Renal endothelin system and excretory function in Wistar-Kyoto and Long-Evans rats. Acta Physiol. 2006;186(1):67-76.
20. Forbes JM, Hewitson TD, Becker GJ, Jones CL. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Int. 2001;59:1333-1341.
21. Safirstein R. Endothelin: the yin and yang ischemic acute renal failure. Kidney Int. 2001;59:1590-1591.
22. Lehrke I, Waldherr R, Ritz E, Wagner J. Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proetinuria. J. Am. Soc. Nephrol. 2001; 12(11):2321-2329.